Elham Mohit

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Escherichia Coli

Positive Breast Cancer

Top Venues

Journal of labelled compounds & radiopharmaceuticals

Biotechnology letters

Molecular biotechnology

Molecular biology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Negar Bozorgchami, Maryam Ahmadzadeh, Dara Hatamabadi, Abdolreza Yazdani, Soraya Shahhosseini, Elham Mohit
Preparation, Characterization, and Radiolabeling of Anti-HER2 scFv With Technetium Tricarbonyl and Stability Studies. Journal of labelled compounds & radiopharmaceuticals 67 (5) (2024)
Elham Sharif, Navid Nezafat, Fatemeh Maghsood Ahmadi, Elham Mohit
In Silico Design of CT26 Polytope and its Surface Display by ClearColi™-Derived Outer Membrane Vesicles as a Cancer Vaccine Candidate Against Colon Carcinoma. Applied biochemistry and biotechnology (2024)
Negar Bozorgchami, Maryam Ahmadzadeh, Dara Hatamabadi, Abdolreza Yazdani, Soraya Shahhosseini, Elham Mohit
Preparation, Characterization, and Radiolabeling of Anti-HER2 scFv With Technetium Tricarbonyl and Stability Studies. Journal of labelled compounds & radiopharmaceuticals (2024)
Negar Bozorgchami, Maryam Ahmadzadeh, Dara Hatamabadi, Abdolreza Yazdani, Soraya Shahhosseini, Elham Mohit
Preparation, Characterization, and Radiolabeling of Anti-HER2 scFv With Technetium Tricarbonyl and Stability Studies. Journal of labelled compounds & radiopharmaceuticals 67 (5) (2024)
Maryam Ahmadzadeh, Elham Mohit
Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer. Biotechnology letters 45 (3) (2023)
Maryam Ahmadzadeh, Elham Mohit
Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer. Biotechnology letters 45 (3) (2023)
Maryam Ahmadzadeh, Elham Mohit
Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer. Biotechnology letters (2023)
Zahra Movahed, Elham Sharif, Maryam Ahmadzadeh, Navid Nezafat, Hoda Jahandar, Elham Mohit
Different strategies for expression and purification of the CT26-poly-neoepitopes vaccine in Escherichia coli. Molecular biology reports 49 (2) (2022)
Elham Sharif, Zohre Eftekhari, Elham Mohit
The Effect of Growth Stage and Isolation Method on Properties of ClearColi™ Outer Membrane Vesicles (OMVs). Current microbiology 78 (4) (2021)
Maryam Ahmadzadeh, Farzaneh Farshdari, Leila Nematollahi, Mahdi Behdani, Elham Mohit
Anti-HER2 scFv Expression in Escherichia coli SHuffle®T7 Express Cells: Effects on Solubility and Biological Activity. Molecular biotechnology 62 (1) (2020)